These apparently conflicting findings could be explained by a biphasic effect of GDF15 observed on progression of cancer: inhibition of carcinogenesis in normal tissue at early stages of tumor development and promotion of tumor at late stages of the disease [48]. This evidence concerns the gene GDF15 and cancer.